Sir:
In the preceding papers1,2), we reported the preparation of some fluorinated antibiotics, fluorovulgamycins and fluoroactinomycins, by the combined use of fluorinated precursors and 19 OF NMR spectroscopy . During the course of the investigation on the preparation of fluoroactinomycin X2, 5-fluorotryptophan proved to be incorporated into fluoroactinomycin X2, while 6-fluorotryptophan (6FTrp) was not. This could be reasonably explained by considering the biosynthetic pathway3,4) of actinocin with C-6 of tryptophan corresponding to C-6 of actinocin to be methylated. Therefore, the fluorine atom at C-6 in tryptophan would inhibit the formation of 6-fluoroactinomycin.
In spite of failure to produce fluoroactinomycin X2, two fluorine resonances were observed in the ethyl acetate extract of the fermentation broth of Streptomyces sp. H-63 supplemented with 6FTrp. In this paper, isolation and structure determination of metabolites responsible for these signals are reported.
Streptomyces sp. H-63 was grown at 27°C in 500-m1 Erlenmeyer flasks, each containing 100 ml of a medium consisting of soluble starch 2.5%, soybean meal 1.5 %, dry yeast 0.2 % and CaCO3 0.4%. After 48 hours of cultivation, 6FTrp was added to the culture medium at the concentration of 300 pg/ml and the cultivation was continued for a further 48 hours. Two fluorine signals (8F -125.0 and -114.0) derived from the metabolites of 6FTrp were recognized in the ethyl acetate extract of the fermentation broth by the use of 'OF NMR spectroscopy. The isolation procedure of these metabolites is depicted in Fig. 1 .
The filtered broth (1 liter) was extracted with EtOAc (400 ml) and the organic layer was evaporated to dryness. The oily residue thus obtained was dissolved in MeOH and applied to a Sephadex LH-20 column which was developed with MeOH. The combined fraction showing a fluorine signal at 5F -125.0 was concentrated. Further purification was carried out by preparative TLC using CHCl3 -MeOH (85: 15) as a developer, yielding purified 1 (2 mg). Another metabolite, 2, was purified in the same way to give a pure form (I mg).
Physico-chemical properties of 1 were as follows: UV .lm'aoi' nm (s) 219 (23,000), 282 (4,300); EI-MS m/z 179 (M+). The 1H NMR spectral data (DMSO-d6) showed the following signals: 7.48 ppm (IH, dd, J=9 and 5 Hz), 7.12 (1H, d, J=1 Hz), 7.10 (1H, dd, J=10 and 2 Hz), 6 .80 (IH, dt, J=9 and 2 Hz), 4.60 (1H, t, J=5 Hz), 3.63 (2H, m), 2.80 (2H, dd, J=6 and 1 Hz). This compound proved to be identical with 6-fluorotryptophol by comparison of the 1H NMR spectra between 1 and 6FTrp (data not shown).
Compound 2 showed absorption maxima at 242 nm (s=7,000) and 293 (s=2,000) in the UV spectrum. The molecular formula of 2 was established as C10H10O2NF by high resolution mass spectroscopy (found: 195.0706; calcd for C1OH10O2NF: 195.0696) and NMR spectra. The 1H NMR spectrum in CD3OD (Fig. 2) showed the following signals; 7.19 ppm (1H, dd, J=8 and 5 Hz), 6 .39 (1H, m) and 6.27 (1H, dd, J=10 190  180  170  160  150  140  130  120  110  100  90  80  70  60  50  40  30 ppm data described above, the structure of 2 was established to be 3a-hydroxy-6-fluoroindoline (HFI) as shown in Fig. 4 . Although 3a-hydroxyindoline (HI) was already synthesized through a photosensitized oxygenation of tryptophol by SAITO et al.5), this is the first report of the isolation of a HI derivative as a natural product. It should be emphasized that HFI was not detectable until 19F NMR was employed. HI and HFI displayed anti-platelet aggregation activities in a system6), using adenosine diphosphate as an aggregating agent. On rabbit platelet aggregation, inhibitory activities of HFI and HI at 2 mm were 76.8 % and 9.1 %, respectively (papaverine hydrochloride inhibited rabbit platelet aggregation completely at 0.2 mm). It is to be noted that introduction of a fluorine atom resulted in the enhancement of anti-platelet aggregating activity of HI. No inhibition activities of HI and HFI was observed at the concentration of 100 ,ug/ml against Bacillus subtilis and Escherichia coli. 
